Statistics

Total Visits

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study85

Select a period of time:

Number of views in the range

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study36

Views

Views
April 20253
May 20255
June 20255
July 202513
August 20254
September 20256
October 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States16
Brazil10
Hong Kong3
Argentina1
Austria1
Ecuador1
Spain1
United Kingdom1
Morocco1
Paraguay1
 

Top cities views

Views
Hong Kong3
Bauru1
Belo Horizonte1
Campo Novo do Parecis1
Canton1
Casablanca1
Cincinnati1
Ciudad del Este1
Contagem1
Council Bluffs1